3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Breast
1
Conditions
Colorectal Neoplasms
1
Breast Neoplasms
1
Brain Neoplasms
1
Interventions
entrectinib
2
tucatinib
1
sodium thiosulfate
1
Trastuzumab
1
Restraint, Physical
1
Capecitabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has announcements
×
Brain Neoplasms
×
tucatinib
×
Clear all
NCT02614794
2023-08-14
HER2CLIMB
Seagen Inc.
Phase 2
Completed
612 enrolled
30 charts
1 FDA